Antitumor activity of ASP8273 300 mg in subjects with EGFR mutation-positive non-small cell lung cancer: Interim results from an ongoing phase 1 study Meeting Abstract
| Authors: | Yu, H. A.; Spira, A. I.; Horn, L.; Weiss, J.; West, H. J.; Giaccone, G.; Evans, T. L.; Kelly, R. J.; Desai, B. B.; Krivoshik, A.; Fleege, T. E.; Poondru, S.; Jie, F.; Aoyama, F. P. K.; Whitcomb, D. A.; Keating, A. T.; Oxnard, G. R. |
| Abstract Title: | Antitumor activity of ASP8273 300 mg in subjects with EGFR mutation-positive non-small cell lung cancer: Interim results from an ongoing phase 1 study |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 468s |
| Language: | English |
| ACCESSION: | WOS:000404711506197 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9050 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9050 -- Source: Wos |
